MACRO 8 minutes to read

Steen's Chronicle: China going counter-cyclical

Steen Jakobsen

Chief Economist & CIO

Summary:  The global economy is headed into contraction, and the spotlight is on China's response.


It is a great honour to have Dr. Charles Su of CIB Research as guest columnist for this latest edition of Steen's Chronicle. Dr. Su will be a keynote speaker at Saxo's upcoming Gateway to China series of events to be held in Copenhagen on March 13, in London on March 20, and in Hong Kong on March 27.

Click here to sign up for this exclusive opportunity to learn how to unlock opportunities within the world’s second-largest economy.
 

Since 2018, the global economy has moved towards a downturn while the supply chain realignment – of which the China/US trade talks are a major component – accelerates. For investors looking to forecast the coming changes, the Federal Reserve's apparent pausing of its quantitative tightening plans and the changes seen in the Chinese credit cycle are key factors.

In Dr. Su's attached presentation, he also notes that the World Trade Organization is facing 'judgment day' at the 2019 Japan G20 summit as the fractures within the present multilateral system of global trade make themselves more apparent.
Source: CIB Research
In terms of the China/US trade negotiations, a deal in which China purchases more US goods will not be without its costs; the question is, who among the country's present trade partners will feel the most pain? 
Source: CIB Research
China's shift from deleveraging to counter-cyclical moves is a key component of our outlook for 2019 and 2020. With China and the Fed loosening policy, Dr. Su sees recession as unlikely over this timespan while also noting the possibility of outperformance among emerging market assets.

For a full copy of Dr. Su's presentation on China going counter-cyclical, please click here.
Disclaimer

Saxo Capital Markets (Australia) Pty Ltd prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Combined Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)